|Barclays Capital Inc. c/o Broadridge Financial Solutions 1155 Long Island Avenue Edgewood, NY 11717 Telephone: 1-888-603-5847 email@example.com||Deutsche Bank Securities Inc. Attention: Prospectus Department 60 Wall Street New York, NY 10005-2836 Telephone: 1-800-503-4611 Email: firstname.lastname@example.org|
|Credit Suisse Securities (USA) LLC c/o Credit Suisse Prospectus Department One Madison Avenue New York, NY 10010 Telephone: 1-800-221-1037 Email: email@example.com||Goldman, Sachs & Co. Attention: Prospectus Department 200 West Street New York, NY 10282 Telephone: 866-471-2526 E-mail:firstname.lastname@example.org|
Delek US Holdings, Inc. (NYSE: DK) (“Delek US”) announced today the pricing of an underwritten secondary offering of 9,000,000 shares of its common stock offered by Delek Hungary Holding Limited Liability Company (the “Selling Stockholder”) at $39.50 per share. The underwriters have been granted a 30-day option to purchase up to an additional 1,350,000 shares of common stock from the Selling Stockholder at the same price, less underwriting discounts. The offering was upsized to 9,000,000 shares of common stock from the original offering size of 7,825,000 shares of common stock. The offering is expected to close on or about March 20, 2013, subject to customary closing conditions. Barclays Capital Inc., Deutsche Bank Securities Inc., Credit Suisse Securities (USA) LLC and Goldman, Sachs & Co. are acting as joint book-running managers for the offering. A shelf registration statement (including a prospectus) for the offering to which this communication relates was previously filed by Delek US with the U.S. Securities and Exchange Commission (“SEC”) and became effective on February 7, 2011. A preliminary prospectus relating to the offering has been filed with the SEC. The offering will be made only by means of a prospectus supplement and accompanying base prospectus. Copies of the prospectus supplement and the accompanying prospectus relating to these securities may be obtained without charge from:
This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.